|
1
|
Cheng TYD, Cramb SM, Baade PD, Youlden DR,
Nwogu C and Reid ME: The international epidemiology of lung cancer:
latest trends, disparities, and tumor characteristics. J Thorac
Oncol. 11:1653–1671. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sarries C, Haura EB, Roig B, Taron M, Abad
A, Scagliotti G and Rosell R: Pharmacogenomic strategies for
developing customized chemotherapy in non-small cell lung cancer.
Pharmacogenomics. 3:763–780. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sharma D, Newman TG and Aronow WS: Lung
cancer screening: history, current perspectives, and future
directions. Arch Med Sci. 11:1033–1043. 2015.PubMed/NCBI
|
|
4
|
Pore M, Meijer C, de Bock GH, Boersma-van
Ek W, Terstappen LW, Groen HJ, Timens W, Kruyt FA and Hiltermann
TJ: Cancer stem cells, epithelial to mesenchymal markers, and
circulating tumor cells in small cell lung cancer. Clin Lung
Cancer. 17:535–542. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Shintani Y, Fujiwara A, Kimura T, Kawamura
T, Funaki S, Minami M and Okumura M: IL-6 secreted from cancer
associated fibroblasts mediates chemoresistance in non-small-cell
lung cancer by increasing epithelial-mesenchymal transition
signaling. J Thorac Oncol. 11:1482–1492. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rahman MA, Barger JF, Lovat F, Gao M,
Otterson GA and Nana-Sinkam P: Lung cancer exosomes as drivers of
epithelial mesenchymal transition. Oncotarget. 7:54852–54866.
2016.PubMed/NCBI
|
|
7
|
Emmons MF, Faião-Flores F and Smalley KS:
The role of phenotypic plasticity in the escape of cancer cells
from targeted therapy. Biochem Pharmacol. 122:1–9. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fan Z, Jiang H, Wang Z and Qu J:
Atorvastatin partially inhibits the epithelial-mesenchymal
transition in A549 cells induced by TGF-β1 by attenuating the
upregulation of SphK1. Oncol Rep. 36:1016–1022. 2016.PubMed/NCBI
|
|
9
|
Ninsontia C, Phiboonchaiyanan PP and
Chanvorachote P: Zinc induces epithelial to mesenchymal transition
in human lung cancer H460 cells via superoxide anion-dependent
mechanism. Cancer Cell Int. 16:482016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen JS, Liang LL, Xu HX, Chen F, Shen SL,
Chen W, Chen LZ, Su Q, Zhang LJ, Bi J, et al: miR-338-3p inhibits
epithelial-mesenchymal transition and metastasis in hepatocellular
carcinoma cells. Oncotarget. Jun 17–2016.(Epub ahead of print).
|
|
11
|
Hsiao YJ, Su KY, Hsu YC, Chang GC, Chen
JS, Chen HY, Hong QS, Hsu SC, Kang PH, Hsu CY, et al: SPANXA
suppresses EMT by inhibiting c-JUN/SNAI2 signaling in lung
adenocarcinoma. Oncotarget. 7:44417–44429. 2016.PubMed/NCBI
|
|
12
|
Ge A, Ma Y, Liu YN, Li YS, Gu H, Zhang JX,
Wang QX, Zeng XN and Huang M: Diosmetin prevents TGF-β1-induced
epithelial-mesenchymal transition via ROS/MAPK signaling pathways.
Life Sci. 153:1–8. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bo H, Zhang S, Gao L, Chen Y, Zhang J,
Chang X and Zhu M: Upregulation of Wnt5a promotes
epithelial-to-mesenchymal transition and metastasis of pancreatic
cancer cells. BMC Cancer. 13:4962013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lee SO, Yang X, Duan S, Tsai Y, Strojny
LR, Keng P and Chen Y: IL-6 promotes growth and
epithelial-mesenchymal transition of CD133+ cells of
non-small cell lung cancer. Oncotarget. 7:6626–6638.
2016.PubMed/NCBI
|
|
15
|
Zhou HS, Su XF, Fu XL, Wu GZ, Luo KL, Fang
Z, Yu F, Liu H, Hu HJ, Chen LS, et al: Mesenchymal stem cells
promote pancreatic adenocarcinoma cells invasion by transforming
growth factor-β1 induced epithelial-mesenchymal transition.
Oncotarget. 7:41294–41305. 2016.PubMed/NCBI
|
|
16
|
Rhee KJ, Lee JI and Eom YW: Mesenchymal
stem cell-mediated effects of tumor support or suppression. Int J
Mol Sci. 16:30015–30033. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang Y, Fu B, Sun X, Li D, Huang Q, Zhao W
and Chen X: Differentially expressed microRNAs in bone marrow
mesenchymal stem cell-derived microvesicles in young and older rats
and their effect on tumor growth factor-β1-mediated
epithelial-mesenchymal transition in HK2 cells. Stem Cell Res Ther.
6:1852015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kawata M, Koinuma D, Ogami T, Umezawa K,
Iwata C, Watabe T and Miyazono K: TGF-β-induced
epithelial-mesenchymal transition of A549 lung adenocarcinoma cells
is enhanced by pro-inflammatory cytokines derived from RAW 264.7
macrophage cells. J Biochem. 151:205–216. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Song J, Feng L, Zhong R, Xia Z, Zhang L,
Cui L, Yan H, Jia X and Zhang Z: Icariside II inhibits the EMT of
NSCLC cells in inflammatory microenvironment via down-regulation of
Akt/NF-κB signaling pathway. Mol Carcinog. 56:36–48. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yamauchi Y, Kohyama T, Takizawa H,
Kamitani S, Desaki M, Takami K, Kawasaki S, Kato J and Nagase T:
Tumor necrosis factor-alpha enhances both epithelial-mesenchymal
transition and cell contraction induced in A549 human alveolar
epithelial cells by transforming growth factor-beta1. Exp Lung Res.
36:12–24. 2010. View Article : Google Scholar : PubMed/NCBI
|
